N/A N=983 Safety Assessment of Angioplasty Procedures
Angiospastic; Disorder
Primary: Number of Major Adverse Cardiac Events (MACE) — 9; 6; 2; 119 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=200 Objective Randomised Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina
Stable Angina
Primary: Exercise Time on Treadmill — 28.4; 11.8 seconds
N/A N=93 AngioSculpt® Coronary Bifurcation Study
Coronary Artery Disease · Myocardial Ischemia
Primary: Procedural Success — 91.4 percentage of participants
N/A N=60 Rotational Atherectomy Combined With Cutting Balloon to Optimize Stent Expansion in Calcified Lesions
Coronary Artery Disease · Atherosclerosis
Primary: Minimum Stent Area After Percutaneous Coronary Intervention — 6.7; 6.9 mm^2
N/A N=51 PCI Alternative Using Sustained Exercise
Cardiovascular Disease
Primary: Myocardial Perfusion Reserve — 2.76; 2.47; 2.82; 2.52 Ratio
N/A N=203 Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?
Coronary Artery Disease
Primary: Estimation of Number of Cases Where FFR Data Results in a Change in the Management Strategy (Number of Vessel Requiring Treatment and/or PCI vs Medical vs CABG) — 147…
N/A N=301 Balloon Pump Assisted Coronary Intervention Study
Coronary Artery Disease · Left Ventricular Dysfunction
Primary: Major Adverse Cardiac and Cerebrovascular Events — 23; 24 Participants
N/A N=21 PET MYOCARDIAL Blood Flow Comparison to Coronary CTA and CT-FFR
Coronary Artery Disease
Primary: Number of Flow-limiting Coronary Artery Stenosis on CT — 8 Coronary arteries
N/A N=15 Coronary Flow Reserve Following Orbital Atherectomy
Coronary Artery Disease
Primary: Coronary Flow Reserve (CFR) — 2.23 Ratio
Phase 2 N=10 CorPath™ 200: Robotically-Assisted Percutaneous Coronary Intervention (PCI)
Coronary Artery Disease
Primary: Clinical Procedural Success — 100 percentage of participants
N/A N=20 Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease
Peripheral Arterial Disease
Primary: Device Technical Success — 29 lesions
N/A N=163 The Asahi Intecc PTCA Chronic Total Occlusion Study
Coronary Artery Disease · Coronary Artery Chronic Total Occlusion
Primary: Procedure Success — 119 Participants
N/A N=86 Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
Coronary Artery Disease
Primary: In Stent Mean Cross-sectional Area of Neo-intimal Tissue Coverage — 1.381; 0.949 mm^2
Phase 2 N=164 Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)
Coronary Artery Disease · Coronary Disease · Myocardial Ischemia
Primary: Percentage of Participants With Clinical Procedural Success — 97.6 percentage of participants
N/A N=160 Novel Angioplasty Using Coronary Accessor
Patency of the Radial Artery
Primary: Number of Patients With Radial Artery Occlusion — 3; 0 Participants
Phase 2 N=41 PERVIDEO I Registry, The Lutonix Paclitaxel-Coated Balloon Catheter for the Treatment of Coronary In-Stent Restenosis
In-Stent Restenosis
Primary: Percent Diameter Stenosis (%DS) in the Analysis Segment — 36.0 Percentage stenosis of vessel diameter
N/A N=500 Physiologic Assessment of Coronary Stenosis Following PCI
Coronary Artery Disease · Coronary Stenosis · Angina, Unstable
Primary: Number of Participants With Residual Ischemia (iFR <0.90) — 112 participants
N/A N=150 Chronic Total Occlusion Percutaneous Coronary Intervention Study
Chronic Total Occlusion · Ischemic Heart Disease · Chronic Total Occlusion of Coronary Artery
Primary: Number of Participants With Procedure Success — 121 Participants
Phase 3 N=60 Evaluation of Coronary Luminal Diameter Enlargement With Emerge™ 1.20 mm PTCA Dilatation Catheter
Coronary Artery Disease
Primary: Device Procedural Success — 98.3 percentage of participants
N/A N=136 Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease
Coronary Stenosis · Coronary Artery Stenosis · In-stent Restenosis
Primary: Number of Device Procedural Success(Lesions Level) — 68; 68 lesions
Phase 2 N=103 Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
Acute Myocardial Infarction
Primary: Infarct Size on Baseline Cardiac Magnetic Resonance Imaging (cMRI) — 20.1; 21.0 ml — p=0.90
N/A N=1,500 A Comparison of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery in Patients With Multivessel Coronary Artery Disease
Coronary Disease · Coronary Stenosis
Primary: MACCE — 80; 51 Participants — p=0.35
N/A N=214 Outcome of Coronary High Angulated Bifurcation Lesions Treated With Kissing Ballooning or Sequential Ballooning Techniques
Stable Angina
Primary: Percentage of Participants With Major Adverse Cardiac Events(MACE) — 1.72; 6.86 percentage of participants
N/A N=300 Electrophysiological Effects of Late PCI After MI
Cardiovascular Diseases · Heart Diseases · Myocardial Infarction
Primary: Short-termed Fractal Scaling Exponent (Alpha 1) — 0.01; -0.03 unit-less — p=0.34
N/A N=371 Dynamic Coronary Roadmap for Contrast Reduction
Coronary Artery Disease
Primary: Total Percutaneous Coronary Intervention (PCI) Iodinated Contrast Volume — 64.6; 90.8 ml
Phase 2 N=40 A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks
Acute Myocardial Infarction
Primary: Percent Diameter Stenosis of the Culprit Lesion Following the First Bolus of Study Drug Prior to Primary Percutaneous Coronary Intervention — 100; 100 Percent diameter…
N/A N=1,005 Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
Coronary Arteriosclerosis
Primary: Major Adverse Cardiac Events — 67; 91 participants
N/A N=400 Study of the CAT RX Aspiration Catheter When Used in Patients With Large Occlusive Thrombus in Coronary Arteries
Coronary Vessel Occlusion
Primary: Composite of: — 14 Participants
N/A N=300 Pivotal Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon
Peripheral Arterial Disease
Primary: Patency at 12 Month Post-procedure — 53; 135 Participants
N/A N=2,487 ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)
Coronary Artery Disease · Coronary Stenosis · Atherosclerosis
Primary: Imaging Outcome (Powered): Minimal Stent Area (MSA) — 5.72; 5.36 mm^2 — p=<0.0001